Korea’s omicron plan leaves vulnerable patients under 60 on their own
Social affairsFeb 9, 2022
COVID-19 patients recovering at home under the age of 60 will no longer be provided care and monitoring unless they are on Paxlovid, the Pfizer oral antiviral treatment, raising concerns for younger but vulnerable patients. Amid an omicron surge, a record 168,000 patients were under home recovery as of Monday afternoon across South Korea, exceeding the manageable maximum of 166,000 that was set previously by the government. Home recovery became the default care arrangement for patients of